期刊文献+

用SYBR green Ⅰ法和流式细胞术体外评价3种青蒿素类药物的抗疟活性 被引量:2

Evaluation on antimalarial activity of 3 artemisinin drugs using SYBR green Ⅰ and flow cytometry in vitro
原文传递
导出
摘要 目的 用SYBR green Ⅰ法和流式细胞术评价3种青蒿素类药物对体外培养恶性疟原虫的抗疟活性. 方法 采用SYBR green Ⅰ法观察不同浓度的青蒿素(arteminisinin,ART)、蒿甲醚(artemether,AM)及双氢青蒿素(dihydroartemisinin,DHA)对体外培养的恶性疟原虫增殖的抑制作用.ART、AM、DHA的抑制浓度依次为6、6×10^-1、6×10^-2、6×10^-3、6×10^-4 μmol/L,4、4×10^-1、4×10^-2、4×10^-3、4× 10^-4 μmol/L及3×10^-1、3×10^-2、3×10^-3、3×10^-4、3×10^-5 μmol/L,设空白组与对照组.体外药物作用72 h后,SYBR green Ⅰ法测得其抑制率,用50%抑制浓度(50% inhibitory concentraton,IC50)及95%抑制浓度(95% inhibitory concentraton,IC95)反映其抑制作用,并与流式细胞术所测得的疟原虫DNA含量的变化进行比较. 结果 SYBR green Ⅰ法结果显示其抑制率随药物浓度的增加而增大,ART、AM与DHA的IC50值分别为11.29、3.32、0.66 nmol/L,IC95值分别为42.55、17.89、4.02 nmol/L;流式细胞术结果中其DNA含量随药物浓度的降低而增加,与SYBR green Ⅰ法结果一致且更具直观性. 结论 SYBR green Ⅰ法的灵敏性与流式细胞术的直观性可以满足体外测定抗疟药对疟原虫抑制作用的需要,均可适于抗疟药物体外活性评价;ART、AM与DHA的体外抗疟活性由高到低的次序为DHA>AM>ART. Objective To evaluate the antimalarial activity against Plasmodiumfalciparum in vitro by SYBR green Ⅰ and flow cytometry.Methods SYBR green Ⅰ was used to evaluate the inhibition to proliferation of Plasmodium falciparum in vitro treated by artimisinin(ART),artemether(AM) and dihydroartemisinine(DHA) at different concentrations.The intervention concentrations of ART,AM and DHA were 6,6×10^-1,6×10^-2,6×103,6×10^-4μmol/L,4,4×10^-1,4×10^-2,4×10^-3,4×10^-4 μmol/L,and 3×10^-1,3×10^-2,3×10^-3,3×10^-4,3×10^-5 μmol/L respectively,a blank control group was set up.After 72 h of drug intervention in vitro,the inhibition rate was measured using SYBR green Ⅰ,the 50% inhibitory concentration (IC50) and 95% inhibition concentration (IC95) were used to reflect the inhibition activity,then compared with the changes of DNA content of malaria parasites measured by flow cytometry.Results SYBR green Ⅰ showed the inhibition rates increased as dose of ART increased,The IC5o values of ART,AM and DHA were 11.29,3.32,0.66 nmol/L; IC95 values were 42.55,17.89,4.02 nmol/L respectively.At the same time,the results of the flow cytometry showed the content of DNA decreased with the increase of drug concentration,agreeing with the results of SYBR green Ⅰ and being objectively perceived.Conclusion The sensitivity of SYBR green Ⅰ and intuitiveness of flow cytometry could meet the requirements of evaluation on antimalarial activity of artemisinin-based antimalarial drugs against Plasmodiumfalciparum in vitro; The order from high to low of antimalarial activity is DHA〉AM〉ART.
出处 《国际医学寄生虫病杂志》 CAS 2014年第4期218-222,共5页 International JOurnal of Medical Parasitic Diseases
基金 国家自然科学基金(81373364)
关键词 SYBR green Ⅰ法 流式细胞术 青蒿素 蒿甲醚 双氢青蒿素 恶性疟原虫 SYBR green Ⅰ Flow cytometry Artimisinin Artemether Dihydroartemisinine Plasmodi-um falciparum
  • 相关文献

参考文献15

  • 1杜坤庭,葛勤利,杨伟捷,万顺梅,罗菲.蒿甲醚注射液联合复方磷酸萘酚喹片治疗恶性疟疾疗效观察[J].中国医药指南,2010,8(16):106-107. 被引量:3
  • 2Chen H, Sun B, Jiang H, et al. Dihydroartemisinin inhibits growth of pancreatic cancer cell in vitro and in vivo [J]. Anticancer Drugs, 2009, 20(2): 131-140.
  • 3Galal AM, Gul W, Slade D, et al. Synthesis and evaluation of di- hydroartemisinin and dihydroartemisitencetal dimers showing anti- cancer and antiprotozoal activity[J]. Bioorg Med Chem, 2009, 17(2) : 741-751.
  • 4Co EM, Dennull RA, Reinbold DD, et al. Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay [J]. An- timicrob Agents Chemother, 2009, 53(6): 2557-2563.
  • 5Izumiyama S, Omura M, Takasaki T, et al. Plasmodium falci- parum: development and validation of a measure of intraerythro- cytic growth using SYBR Green I in a flow cytometer[J]. Exp Para- sitol, 2009, 121: 144-150.
  • 6Rason MA, Randriantsoa T, Andrianantenaina H, et al. Perfor- mance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium fcdciparum clinical isolates[J]. Trans R Soc Trop Med Hyg, 2008, 102(4): 346-351.
  • 7Bacon DJ, Latour C, Lueas C, et al. Comparion of a SYBR green I-based assay with a histidine-rich protein Ⅱ enzyme-linked im- munosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates[J]. Antimicrob Agents Chemother, 2007, 51(4) : 1172-1178.
  • 8Johnson JD, Dennull RA, Gerena L, et al. Assessment and con- tinued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening [J]. Antimicrob Agents Chemother, 2007, 51(6): 1926-1933.
  • 9黄芳,汤林华,王琴美,倪奕昌.微量荧光法体外测定恶性疟原虫对4种常用抗疟药的敏感性[J].中国寄生虫学与寄生虫病杂志,2006,24(1):41-44. 被引量:4
  • 10Eyase FL, Akala HM, Ingasia L, et al. The role of pfmdrl and pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in Western-Kenya P. falciparum sam- ples during 2008 - 2011[J]. PLoS One, 2013, 8(5) : 1-8.

二级参考文献79

共引文献14

同被引文献3

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部